Hot Stocks Of The Day (HGSI, KLAC, MCK, QLIK, TLAB)

Human Genome Sciences (NASDAQ:HGSI) went up 0.11% to $14.24 on a traded volume of 484k shares. The shareholders of Human Genome Sciences are not entitled to more time to consider the offer, as told by U.S. District Judge Sue L. Robinson. Human Genome Sciences Inc investors lost a bid to extend GlaxoSmithKline Plc deadline of tomorrow to decide whether to tender their shares for a $3 billion buyout.

KLA-Tencor Corporation (NASDAQ:KLAC) soared 1.89% to $50.60. The Company reported first quarter EPS of $1.49, beating the analyst estimate of $1.31. Revenue for the quarter was $892.5 million versus the consensus estimate of $873.16 million.

McKesson Corporation (NYSE:MCK) went up 0.76% to $92.97 after the company released first quarter results. Adjusted income was $372 million or $1.55 per share compared to $323 million or $1.27 per share in the prior year quarter. However, analysts expected the company to earn $1.48 per share for the quarter.  Total revenues for the quarter rose 3% to $30.80 billion.

Qlik Technologies Inc (NASDAQ:QLIK) among the gainers and the stock surged up 20.95% to $21.36. The Company reported second quarter net loss of $2.04 million or $0.02 per share compared to $2.71 million or $0.03 per share in the prior year period. Adjusted income was $1.68 million or $0.02 per share versus 1.25 million or $0.01 per share in the prior year quarter.

Total revenues increased 16% to $85.80 million. The Company expects third quarter adjusted net income in the range of $0.02 to $0.04 per share. Revenues for the third quarter are anticipated in the range of $87.0 million to $90.0 million.

Tellabs Inc (NASDAQ:TLAB) jumped up 10.48% to $3.32 after the Company reported second quarter results. Net loss was $5 million or $0.01 per share compared to $29 million or $0.08 per share in the same period last year. Profit was $6 million or $0.02 per share compared to a loss of $14 million or $0.04 per share in the previous year quarter. Revenues were $288 million versus $317 million in the prior year quarter. Analysts expected revenues of $287.57 million.